A rapid, easy, and scalable whole blood monocyte CD169 assay for outpatient screening during SARS-CoV-2 outbreak, and potentially other emerging disease outbreaks

OBJECTIVE: The COVID-19 corona virus disease outbreak is globally challenging health systems and societies. Its diagnosis relies on molecular methods, with drawbacks revealed by mass screening. Upregulation of neutrophil CD64 or monocyte CD169 has been abundantly reported as markers of bacterial or...

Descripción completa

Detalles Bibliográficos
Autores principales: Michel, Moïse, Malergue, Fabrice, Ait Belkacem, Inès, Bourgoin, Pénélope, Morange, Pierre-Emmanuel, Arnoux, Isabelle, Miloud, Tewfik, Million, Matthieu, Tissot-Dupont, Hervé, Mege, Jean-Louis, Vitte, Joana, Busnel, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358337/
https://www.ncbi.nlm.nih.gov/pubmed/35959245
http://dx.doi.org/10.1177/20503121221115483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358337/
https://www.ncbi.nlm.nih.gov/pubmed/35959245
http://dx.doi.org/10.1177/20503121221115483

Ejemplares similares